Researchers provide prospective on low-dose radiation biology controversy

May 14, 2013

A review of the current issues in low-dose radiation research authored by two radiation biologists from the Pacific Northwest National Laboratory is the cover story of the May 2013 issue of Radiation Research. The review, by Laboratory Fellow Dr. William F. Morgan and retired PNNL scientist Dr. William J. Bair, highlights critical areas of controversy in low-dose radiation biology, and suggests areas of future research to address these issues.

In "Issues in Low Biology: The Controversy Continues. A Perspective," the authors reiterate that exposure to ionizing radiation, both natural and man-made, is a fact of life. The Fukushima disaster in 2011; the debate over the future of nuclear power; and the increasing use of radiation in medicine, agriculture, the military, national security, research, and industry has focused attention on health and safety issues associated with potential exposures to low-dose, low-dose-rate ionizing radiation.

The of the article is interested investigators. However, Morgan and Bair believe it will help government regulators, policy makers, and funding agencies understand why this is a critical time to address concerns associated with low-dose radiation exposures and the nations ability to deal with them in a rational, scientifically based manner.

Explore further: A rare condition of excruciating eye pain

More information: Morgan WF and WJ Bair. 2013. Issues in Low Dose Radiation Biology: The Controversy Continues. A Perspective. Radiation Research 179, 501-510. DOI: 10.1667/RR3306.1

Related Stories

A rare condition of excruciating eye pain

September 8, 2015

Razor blades. Jabbing needles. Barbed wire. Screaming, howling, red-hot-poker-in-the-eye pain. The impulse to gouge your own eyes out or overdose on sleeping pills – anything to make the pain go away.

Five things women should know about breast cancer

October 2, 2015

Dr. Laura Esserman is filled with hope this Breast Cancer Awareness Month. The UC San Francisco surgeon is gearing up for a five-year study that will tap into technology to improve breast cancer screening and patient outcomes.

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.